Success and failures in MRSA infection control during the COVID-19 pandemic

Private sector facilities in the United States have experienced a resurgence of Methicillin-resistant Staphylococcus aureus (MRSA) hospital-onset infections during the COVID-19 pandemic, which eliminated all gains that were achieved over the last decade. The third quarter of 2021, the Standardized I...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanagh, Kevin T., Cormier, Lindsay E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509631/
https://www.ncbi.nlm.nih.gov/pubmed/36153597
http://dx.doi.org/10.1186/s13756-022-01158-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509631/
https://www.ncbi.nlm.nih.gov/pubmed/36153597
http://dx.doi.org/10.1186/s13756-022-01158-z

Ejemplares similares